scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.74
3.04%
After-hours: Aug 15, 2025, 07:07 PM EDT

scPharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
75.66M 46.81M 71.06M 74.27M
Short-Term Investments
1.02M 29.2M 47.13M 1.01M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
341K 82K 267K 283K
Receivables
11.72M 4.49M n/a n/a
Inventory
13.9M 8.84M 1.23M n/a
Other Current Assets
1.02M 1.16M 1.43M 24K
Total Current Assets
105.85M 92.94M 123.31M 78.28M
Property-Plant & Equipment
1.33M 1.46M 620K 479K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.67M 1.54M 887K 762K
Total Assets
107.52M 94.48M 124.19M 79.04M
Account Payables
3.88M 4M 1.52M 544K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
239K 176K 567K 9.8M
Other Current Liabilities
5.33M 30K 2.23M 31K
Total Current Liabilities
14.88M 13.13M 7.42M 14.85M
Long-Term Debt
51.35M 38.81M 36.79M 7.35M
Other Long-Term Liabilities
26.87M 4.03M 7.54M 367K
Total Long-Term Liabilities
79.32M 44.13M 44.35M 7.72M
Total Liabilities
94.2M 57.26M 51.76M 22.57M
Total Debt
52.69M 40.27M 37.37M 17.64M
Common Stock
5K 4K 3K 3K
Retained Earnings
-366.49M -281.35M -226.54M -189.7M
Comprehensive Income
n/a -1K 32K -1K
Shareholders Equity
13.32M 37.22M 72.43M 56.47M
Total Investments
1.02M 29.2M 47.13M 1.01M